Skip to main content
Erschienen in: Journal of Gastroenterology 3/2010

01.03.2010 | Original Article—Alimentary Tract

The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice

verfasst von: Tomoaki Matsumura, Makoto Arai, Yutaka Yonemitsu, Daisuke Maruoka, Takeshi Tanaka, Takuto Suzuki, Masaharu Yoshikawa, Fumio Imazeki, Osamu Yokosuka

Erschienen in: Journal of Gastroenterology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Rikkunshito is a traditional Japanese medicine that is widely used for treating upper gastrointestinal symptoms. Our purpose is to clarify the effect of Rikkunshito on the levels of peptide hormones and cytokines in healthy humans and mice.

Methods

We administered Rikkunshito, 7.5 g per day, to 21 healthy volunteers for 2 weeks and examined the changes in plasma peptide and hormone levels. In mice, we administered free access to water containing 0, 0.7, 1.1, and 1.4% Rikkunshito for 2 weeks and examined the changes in plasma peptide levels and ghrelin mRNA expression levels in the stomach.

Results

Plasma acylated ghrelin levels at 0, 2, and 6 weeks after the start of administration were 6.7 ± 2.8, 11.7 ± 4.0, and 10.5 ± 4.4 fmol/ml, respectively. The levels at 2 and 6 weeks were significantly higher than that at 0 time (p < 0.01, paired t test). The levels of interleukin 4, interferon γ, and granulocyte colony-stimulating factor in plasma decreased significantly (p < 0.01) after the administration of Rikkunshito. In mice, the levels of plasma acylated ghrelin changed in proportion to the concentration of Rikkunshito in drinking water, and it was revealed by quantitative RT-PCR that the ghrelin mRNA expression level in the stomach was up-regulated.

Conclusion

Rikkunshito increased the plasma acylated ghrelin level in healthy volunteers and normal mice. Additionally, this change was maintained for at least 4 weeks after the end of administration. In mice, Rikkunshito increased the ghrelin mRNA expression level in the stomach.
Literatur
1.
Zurück zum Zitat Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRefPubMed Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656–60.CrossRefPubMed
2.
Zurück zum Zitat Nakazato M, Murakami N, Kojima M, Matuo H, Kangawa K, Matsukura S, et al. A role of ghrelin in the central regulation of feeding. Nature. 2001;409:194–8.CrossRefPubMed Nakazato M, Murakami N, Kojima M, Matuo H, Kangawa K, Matsukura S, et al. A role of ghrelin in the central regulation of feeding. Nature. 2001;409:194–8.CrossRefPubMed
3.
Zurück zum Zitat Wren AM, Seal LJ, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.CrossRefPubMed Wren AM, Seal LJ, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.CrossRefPubMed
4.
Zurück zum Zitat Tack J, Depoortere I, Coulie B, Meulemans A, Janssens J, Peeters T, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55(3):327–33.CrossRefPubMed Tack J, Depoortere I, Coulie B, Meulemans A, Janssens J, Peeters T, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55(3):327–33.CrossRefPubMed
5.
Zurück zum Zitat Strassburg S, Anker SD, Dong JZ, Culler MD, Datta R, Tschöp MH, et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab. 2008;295(1):E78–84.CrossRefPubMed Strassburg S, Anker SD, Dong JZ, Culler MD, Datta R, Tschöp MH, et al. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am J Physiol Endocrinol Metab. 2008;295(1):E78–84.CrossRefPubMed
6.
Zurück zum Zitat Tatsuta M, Iishi H. Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459–62.PubMed Tatsuta M, Iishi H. Effect of treatment with Liu-Jun-Zi-Tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459–62.PubMed
7.
Zurück zum Zitat Tomono H, Ito Y, Watanabe T. Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn J Cancer Chemother. 2006;33:1129–31. Tomono H, Ito Y, Watanabe T. Successful antiemetic treatment of Tsumura rikkunshi-to extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn J Cancer Chemother. 2006;33:1129–31.
8.
Zurück zum Zitat Oka T, Tamagawa Y, Tamagawa Y, Hayashida S, Kaneda Y, Kodama N, et al. Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med. 2007;15:1–21. Oka T, Tamagawa Y, Tamagawa Y, Hayashida S, Kaneda Y, Kodama N, et al. Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med. 2007;15:1–21.
9.
Zurück zum Zitat Takeda H, Sadakane C, Katsurada T, Ohkawara T, Nagai K, Asaka M, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004–13.CrossRefPubMed Takeda H, Sadakane C, Katsurada T, Ohkawara T, Nagai K, Asaka M, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134:2004–13.CrossRefPubMed
10.
Zurück zum Zitat Arai M, Yokosuka O, Takiguchi M, Saisho H, Muramatsu M, Seki N, et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem. 2003;278:29813–8.CrossRefPubMed Arai M, Yokosuka O, Takiguchi M, Saisho H, Muramatsu M, Seki N, et al. Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem. 2003;278:29813–8.CrossRefPubMed
11.
Zurück zum Zitat Arvat E, Gianotti L, Papotti M, Graziani A, Ghigo E, Deghenghi R, et al. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system. Endocrine. 2001;14:35–43.CrossRefPubMed Arvat E, Gianotti L, Papotti M, Graziani A, Ghigo E, Deghenghi R, et al. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system. Endocrine. 2001;14:35–43.CrossRefPubMed
12.
Zurück zum Zitat Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care. 2002;5:391–5.CrossRefPubMed Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care. 2002;5:391–5.CrossRefPubMed
13.
Zurück zum Zitat Wolf I, Sadetzki S, Oberman B, Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 2006;15(106):966–73.CrossRef Wolf I, Sadetzki S, Oberman B, Catane R, Kaufman B, Shimon I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer. 2006;15(106):966–73.CrossRef
14.
Zurück zum Zitat Ataseven H, Bahcecioglu I, Yalniz M, Celebi S, Erensoy A, Ustundag B, et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006;2006:78380.CrossRefPubMed Ataseven H, Bahcecioglu I, Yalniz M, Celebi S, Erensoy A, Ustundag B, et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006;2006:78380.CrossRefPubMed
15.
Zurück zum Zitat Shinomiya T, Fukunaga M, Yokode M, Kangawa K, Nakai Y, Nakai Y, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol. 2005;40:648–53.CrossRefPubMed Shinomiya T, Fukunaga M, Yokode M, Kangawa K, Nakai Y, Nakai Y, et al. Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol. 2005;40:648–53.CrossRefPubMed
16.
Zurück zum Zitat Garcia JM, Garcia-Touza M, Mann D, Smith RG, Cunningham GR, Marcelli M, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90:2920–6.CrossRefPubMed Garcia JM, Garcia-Touza M, Mann D, Smith RG, Cunningham GR, Marcelli M, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90:2920–6.CrossRefPubMed
17.
Zurück zum Zitat Soriano-Guillén L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004;144:36–42.CrossRefPubMed Soriano-Guillén L, Barrios V, Campos-Barros A, Argente J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004;144:36–42.CrossRefPubMed
18.
Zurück zum Zitat Dostálová V, Haluzík M. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res. 2008;58:159–70.PubMed Dostálová V, Haluzík M. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res. 2008;58:159–70.PubMed
19.
Zurück zum Zitat Takamori K, Mizuta Y, Ohba K, Omagari K, Shikuwa S, Kohno S, et al. Relation among plasma ghrelin level, gastric emptying, and psychological condition in patients with functional dyspepsia. J Clin Gastroenterol. 2007;41:477–83.CrossRefPubMed Takamori K, Mizuta Y, Ohba K, Omagari K, Shikuwa S, Kohno S, et al. Relation among plasma ghrelin level, gastric emptying, and psychological condition in patients with functional dyspepsia. J Clin Gastroenterol. 2007;41:477–83.CrossRefPubMed
20.
Zurück zum Zitat Pilichiewicz AN, Feltrin KL, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008;103(10):2613–23.CrossRefPubMed Pilichiewicz AN, Feltrin KL, Wishart JM, Jones KL, Talley NJ, Feinle-Bisset C, et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol. 2008;103(10):2613–23.CrossRefPubMed
21.
Zurück zum Zitat Akamizu T, Iwakura H, Fukunaga M, Nakai Y, Kangawa K, Clinical Study Team FD, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008;158:491–8.CrossRefPubMed Akamizu T, Iwakura H, Fukunaga M, Nakai Y, Kangawa K, Clinical Study Team FD, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008;158:491–8.CrossRefPubMed
22.
Zurück zum Zitat Shindo T, Futagami S, Hiratsuka T, Horie A, Hamamoto T, Ueki N, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion. 2009;79:65–72.CrossRefPubMed Shindo T, Futagami S, Hiratsuka T, Horie A, Hamamoto T, Ueki N, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion. 2009;79:65–72.CrossRefPubMed
23.
Zurück zum Zitat Ringel Y. Brain research in functional gastrointestinal disorders. J Clin Gastroenterol. 2002;35:23–5.CrossRef Ringel Y. Brain research in functional gastrointestinal disorders. J Clin Gastroenterol. 2002;35:23–5.CrossRef
24.
Zurück zum Zitat Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol. 2004;55:137–54.PubMed Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol. 2004;55:137–54.PubMed
26.
Zurück zum Zitat Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today. 2008;13:234–9.CrossRefPubMed Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today. 2008;13:234–9.CrossRefPubMed
27.
Zurück zum Zitat Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–96.CrossRefPubMed Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387–96.CrossRefPubMed
28.
Zurück zum Zitat Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707–20.CrossRefPubMed Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707–20.CrossRefPubMed
29.
Zurück zum Zitat Dixit VD, Schaffer EM, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57–66.PubMed Dixit VD, Schaffer EM, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57–66.PubMed
30.
Zurück zum Zitat Zhang M, Yuan F, Chen H, Qiu X, Fang W. Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim Biophys Sin. 2007;39:974–81.PubMed Zhang M, Yuan F, Chen H, Qiu X, Fang W. Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim Biophys Sin. 2007;39:974–81.PubMed
31.
Zurück zum Zitat Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther. 2008;21:774–9.CrossRefPubMed Kodama T, Ashitani J, Matsumoto N, Kangawa K, Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther. 2008;21:774–9.CrossRefPubMed
Metadaten
Titel
The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice
verfasst von
Tomoaki Matsumura
Makoto Arai
Yutaka Yonemitsu
Daisuke Maruoka
Takeshi Tanaka
Takuto Suzuki
Masaharu Yoshikawa
Fumio Imazeki
Osamu Yokosuka
Publikationsdatum
01.03.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 3/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-009-0166-z

Weitere Artikel der Ausgabe 3/2010

Journal of Gastroenterology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.